2013年美国放射肿瘤学会年会肝脏肿瘤放射治疗研究进展荟萃

方子燕; 黄龙; 黎功

doi:10.3969/j.issn.1001-5256.2014.04.025

2013年美国放射肿瘤学会年会肝脏肿瘤放射治疗研究进展荟萃

DOI: 10.3969/j.issn.1001-5256.2014.04.025

武警总医院肿瘤二科

详细信息

中图分类号: R735.7
计量
- 文章访问数: 2641
- HTML全文浏览量: 21
- PDF下载量: 530
- 被引次数: 0
出版历程
- 出版日期: 2014-04-20

Research progress in radiotherapy for liver tumors reported in 2013 ASTRO Annual Meeting

Second Department of Oncology, Armed Police General Hospital

摘要

摘要:
随着放射治疗技术的进步,肝脏肿瘤放射治疗疗效的提高,放射治疗为不能手术治疗的患者提供了新的选择。介绍了2013年第55届美国放射肿瘤学会(ASTRO)关于肝脏肿瘤放射治疗方面的进展,主要为立体定向放射治疗(SBRT)治疗肝肿瘤的疗效及毒副作用。未来放射治疗在肝脏肿瘤治疗中的地位将会日益凸显。现将本届会议的主要研究报道分类整理如下。
- 肝肿瘤 /
- 放射疗法 /
- 美国 /
- 综述
Abstract:
With the development of radiotherapy techniques, the efficacy of radiotherapy for liver tumors has been improved, and radiotherapy can be considered as an alternative treatment for patients who are not suitable for surgery.The progress in liver tumor radiotherapy reported in the 55th annual meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO) in 2013, particularly the efficacy and safety of stereotactic body radiation therapy for liver tumors, is reviewed.In the future, radiotherapy may be increasingly used as an effective method in the treatment of liver tumors.The main studies reported at the meeting are sorted as follows in this article.
- liver neoplasms /
- radiotherapy /
- United States /
- review

HTML全文

参考文献(9)

[1]STENMARK MH, CAO Y, WANG H, et al.Indocyanine green for individualized assessment of functional liver reserve in patients undergoing liver radiation therapy[J].Int J Radiat Oncol Biol Phys, 2013, 87 (Suppl 2) :s26-s27.

[2]FENG MU, SCHIPPER MJ, BALTER JM, et al.A phase 2 trial of individualized adaptive stereotactic body radiation therapy (SBRT) for patients at high risk for liver damage[J].Int J Radiat Oncol Biol Phys, 2013, 87 (Suppl 2) :s27.

[3]SANUKI N.Stereotactic ablative body radiation therapy for small hepatocellular carcinoma:outcomes in 185 patients[J].Int J Radiat Oncol Biol Phys, 2013, 87 (Suppl 2) :s321.

[4]QUE J.The efficacy of stereotactic body radiation therapy for unresectable huge hepatocellular carcinoma not eligible for other local modalities[J].Int J Radiat Oncol Biol Phys, 2013, 87 (Suppl 2) :s316.

[5]MAHADEVAN A, CURRY M, LAKE-BAKAAR B, et al.Stereotactic body radiation therapy for unresectable large and multiple hepatocellular carcinoma[J].Int J Radiat Oncol Biol Phys, 2013, 87 (Suppl 2) :s319-s320.

[6]BLACKSBURG SR, ZHANG E, LIU J, et al.Combined transarterial chemoembolization (TACE) and stereotactic body radiation therapy (SBRT) for management of primary hepatocellular carcinoma (HCC) [J].Int J Radiat Oncol Biol Phys, 2013, 87 (Suppl 2) :s319.

[7]GOODMAN B, CALLEY C, MALUCCIO M, et al.Survival efficacy following stereotactic body radiation therapy for limited liver metastases[J].Int J Radiat Oncol Biol Phys, 2013, 87 (Suppl 2) :s190.

[8]YAMASHITA H, HIROSHI O, YASUO M, et al.Comparison between stereotactic body radiation therapy for liver metastases and hepatocellular carcinoma[J].Int J Radiat Oncol Biol Phys, 2013, 87 (Suppl 2) :s321.

[9]MANNINA EM, LASLEY FD, CALLEY C, et al.Role of stereotactic body radiation therapy as a bridge to orthotopic liver transplantation:evaluation of pathological response and outcome[J].Int J Radiat Oncol Biol Phys, 2013, 87 (Suppl 2) :s323-s324.

施引文献

资源附件(0)

访问统计